What is NDC 51662-1315?

51662-1315 is the product NDC for Levophed(R) Norepinephrine Bitartrate, Norepinephrine bitartrate 1 mg/mL injection, solution, concentrate, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 2 package NDCs, shown above in 10- and 11-digit form.

HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Levophed(R) Norepinephrine Bitartrate?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Levophed(R) Norepinephrine Bitartrate NDC 51662-1315

NDC codes

FDA NDC Directory

Product NDC (as listed)51662-1315Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51662-1315Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51662-1315-1	51662131501	4 mL in 1 VIAL, SINGLE-DOSE (51662-1315-1)Marketed from Oct 18, 2018
51662-1315-3	51662131503	10 POUCH in 1 CASE (51662-1315-3) / 1 mL in 1 POUCH (51662-1315-2)Marketed from Sep 26, 2020

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Levophed(R) Norepinephrine Bitartrate
Generic name (nonproprietary): levophed(r) norepinephrine bitartrate
Active ingredients: Norepinephrine bitartrate — 1 mg/mL
Dosage form: Injection, Solution, Concentrate
Route: Intravenous
Labeler: HF Acquisition Co LLC, DBA HealthFirstNDC labeler code 51662
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 007513
Marketing start: Oct 18, 2018
Listing expires: Dec 31, 2026
Other FDA classes: Catecholamines (Chemical structure)
Identifiers: Product ID 51662-1315_ba9ee8b4-ee9c-3d1b-e053-2995a90a11deSPL ID ba9ee8b4-ee9c-3d1b-e053-2995a90a11deSPL set ID 788b6c64-1b6d-0058-e053-2a91aa0aa99cRxCUI 242969UNII IFY5PE3ZRW
Pharmacologic class: Catecholamine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N451662131501 followed by a unit qualifier and the quantity

Package 51662-1315-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 5, 2021.

Indications (excerpt from the label)

INDICATIONS & USAGE For blood pressure control in certain acute hypotensive states (e.g., pheochromocytomectomy, sympathectomy, poliomyelitis, spinal anesthesia, myocardial infarction, septicemia, blood transfusion, and drug reactions). As an adjunct in the treatment of cardiac arrest and profound hypotension.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51662-1315

What is NDC 51662-1315?: 51662-1315 is the product NDC for Levophed(R) Norepinephrine Bitartrate, Norepinephrine bitartrate 1 mg/mL injection, solution, concentrate, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Levophed(R) Norepinephrine Bitartrate.
What is the active ingredient?: Norepinephrine bitartrate.
Who is the labeler?: HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Levophed(R) Norepinephrine Bitartrate?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under NDA 007513

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 007513
Product	Strength	Form · route	Labeler	Product NDC
Levophednorepinephrine bitartrate	Norepinephrine bitartrate 1 mg/mL	Injection, Solution, ConcentrateIntravenous	Hospira, Inc.	0409-0161
Levophednorepinephrine bitartrate	Norepinephrine bitartrate 1 mg/mL	Injection, Solution, ConcentrateIntravenous	Hospira, Inc.	0409-3375